LETTER
Correction: Error in Dosage
D. B. Matchar;
D. C. McCrory;
H. J. Barnett; and
J. R. Feussner
15 September 1994 | Volume 121 Issue 6 | Page 470
In the review article on medical treatment for stroke prevention by Matchar and colleagues [1], a dosage error occurred in the section on nonvalvular atrial fibrillation. The last paragraph of section 4.1.2 discusses the Copenhagen Study, which used an aspirin dosage of 75 mg/d. In the text, this dosage was mistakenly attributed to warfarin.
1. Matchar DB, McCrory DC, Barnett HJ, Feussner JR. Medical treatment for stroke prevention. Ann Intern Med. 1994; 121:41-53.
About Letters
The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:
•Include no more than 300 words of text, three authors, and five references
•Type with double-spacing
•Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.
Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only selectively. Authors will be notified that the letter has been received. If the letter is selected for publication, the author will be notified about 3 weeks before the publication date. Unpublished letters cannot be returned.
Annals welcomes electronically submitted letters.
Top
REFERENCE
Article
